GLAS-A.NEO Glass House Brands Inc.

Healthcare Drug Manufacturers - Specialty & Generic NEO Exchange
2.20 CAD
Close of Oct 30, 2026
2.13 13.79
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is GLAS-A.NEO undervalued?

Graham number

The Graham number of Glass House Brands Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Glass House Brands Inc. fundamental analysis

No fundamental analysis for Glass House Brands Inc. yet.

Glass House Brands Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Glass House Brands Inc.

Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods. The Retail segment owns, and operates retail cannabis stores, and dispensary operation management services. The Wholesale Biomass segment includes propagation, nursery, flowering canopy, dries, processes, and distributes cannabis biomass. The Canna…

Full company profile